705. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Renal Function and in Those Requiring Hemodialysis

Gelijkaardige items

• 722. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Hepatic Function
  door: Wicha, Wolfgang, et al.
  Gepubliceerd in: (2019)
• Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing
  door: Wicha, Wolfgang W, et al.
  Gepubliceerd in: (2019)
• 699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results
  door: Lewis, James H, et al.
  Gepubliceerd in: (2019)
• Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
  door: Bhavnani, Sujata M, et al.
  Gepubliceerd in: (2019)
• Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
  door: File, Thomas M, et al.
  Gepubliceerd in: (2019)